Quoin Pharmaceuticals QNRX Income Statement (2016-2026)

NASDAQ QNRX
$3.98 +0.08 (+2.05%)
At close: Oct 19, 2026 · 4:00 PM EDT
Reported Financials

Quoin Pharmaceuticals Quarterly Income Statement

Periods 29 quarters
Latest Jun 2026

Quoin Pharmaceuticals reported net income of -$5.37M for the quarter ended Jun 2026. This income statement covers 29 quarters of results from Dec 2016 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Income StatementIncome Statement Dec2016 Dec2017 Jun2018 Dec2018 Jun2019 Dec2019 Jun2020 Dec2020 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating items
Operating Interest ExpensesOp. Interest Exp.
Research & DevelopmentR&D
0.26M1.01M0.59M0.73M0.75M0.61M1.09M0.63M0.76M0.83M0.89M0.59M1.08M1.05M2.37M2.05M2.28M3.10M3.43M3.63M
Selling, General & AdministrativeSG&A
1.04M1.97M1.59M1.94M1.58M1.47M1.68M1.63M1.37M1.39M1.57M1.55M1.45M1.35M1.58M1.74M1.74M1.42M1.70M1.85M
Operating ExpensesOpex
1.30M2.98M2.18M2.67M2.33M2.09M2.78M2.26M2.13M2.22M2.46M2.14M2.53M2.41M3.96M3.79M4.02M4.52M5.13M5.47M
Non-operating items
Non Operating Interest Expenses
Interest & Investment IncomeInt & Inv Inc
0.02M0.08M0.15M0.19M0.20M0.14M0.10M0.15M0.10M
Other Non Operating IncomeOther Non Op Inc.
-0.15M-4.52M0.42M0.00M0.00M0.02M-0.03M0.00M0.01M-0.01M0.00M0.03M-0.02M126.00-0.01M0.01M364.00-0.01M0.00M
Non Operating IncomeNon Op. Inc.
-0.10M-8.84M0.49M-0.70M0.08M0.17M0.15M0.20M0.17M0.13M0.16M0.18M0.09M0.14M0.10M0.07M0.17M0.13M0.10M
Net income details
Income towards Parent CompanyParent Net Inc
-1.40M-11.82M-1.68M-2.67M-3.03M-2.00M-2.60M-2.11M-1.93M-2.05M-2.33M-1.97M-2.35M-2.31M-3.81M-3.70M-3.95M-4.30M-5.00M-5.37M
Net Income towards Common StockholdersNet Income
-1.40M-11.82M-1.68M-2.67M-3.09M-2.00M-2.60M-2.11M-1.93M-2.05M-2.33M-1.97M-2.35M-2.31M-3.81M-3.70M-3.95M-4.30M-5.00M-5.37M
Additional items
EPS (Basic)
-0.13-0.26-87.790.00M-394.87-28.92-11.91-74.70-68.31-79.64-38.73-13.68-16.29-17.25-227.56-219.93-234.94-141.05-61.79-66.36
EPS (Diluted)
-0.04-0.26-87.790.00M-394.87-28.92-11.91-74.70-68.31-79.64-38.73-13.68-16.29-17.25-227.56-219.93-234.94-141.05-61.79-66.36
Shares Outstanding
10.52M45.28M0.02M0.00M0.01M0.07M0.22M0.03M0.03M0.03M0.06M0.14M0.14M0.13M0.02M0.02M0.02M0.03M0.08M0.08M
Shares Outstanding (Diluted)Shares Outstanding (Dil.)
34.33M45.28M0.02M0.00M0.01M0.07M0.22M0.03M0.03M0.03M0.06M0.14M0.14M0.13M0.02M0.02M0.02M0.03M0.08M0.08M
Shares Outstanding (Entity)Shares Outstanding (Entity.)
45.28M0.02M0.00M0.01M0.07M0.22M0.03M0.03M0.03M0.06M0.14M0.14M0.13M0.59M0.59M0.59M1.07M2.83M2.83M
Interest ExpensesInt Expense

Quoin Pharmaceuticals Income Statement API

Pull Quoin Pharmaceuticals's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=QNRX&statement=IS&frequency=Quarter&period=all&api_key=YOUR_API_KEY